Find similar content

Source channel @githubtrending · Post #14743 · May 23

#javascript#ecmascript_proposals#es2015#es2019#es6#es7#esnext#javascript#js#polyfill#ponyfill#promise#proposal#proposals#shim#symbol#weakmap core-js is a modular JavaScript library that provides polyfills for modern ECMAScript features up to 2024, including promises, symbols, collections, iterators, typed arrays, and many web standards like URL and structuredClone. It lets you use new JavaScript features in older browsers by loading only the needed parts without polluting the global namespace. It integrates well with tools like Babel and swc for optimized polyfilling. This helps you write modern, compatible code that runs smoothly across different environments, improving development efficiency and user experience. You can customize polyfill usage and even build your own tailored version for your project. https://github.com/zloirock/core-js

Hashtags

#javascript #ecmascript_proposals #es2015 #es2019 #es6 #es7 #esnext #js #polyfill #ponyfill #promise #proposal #proposals #shim #symbol #weakmap

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment